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Abstract. 
 
Fusion of rabies virus with membranes is 
triggered at low pH and is mediated by the viral glyco-
protein (G). The rabies virus-induced fusion pathway 
was studied by investigating the effects of exogenous 
lipids having various dynamic molecular shapes on the 
fusion process. Inverted cone-shaped lysophosphatidyl-
cholines (LPCs) blocked fusion at a stage subsequent to 
fusion peptide insertion into the target membrane. 
Consistent with the stalk-hypothesis, LPC with shorter 
alkyl chains inhibited fusion at lower membrane con-
centrations and this inhibition was compensated by the 
presence of oleic acid. However, under suboptimal fu-
sion conditions, short chain LPCs, which were translo-
cated in the inner leaﬂet of the membranes, consider-
ably reduced the lag time preceding membrane 
merging, resulting in faster kinetics of fusion. This indi-
cated that the rate limiting step for fusion is the forma-
tion of a fusion pore in a diaphragm of restricted hemi-
fusion. The previously described cold-stabilized 
prefusion complex was also characterized. This inter-
mediate is at a well-advanced stage of the fusion pro-
cess when the hemifusion diaphragm is destabilized, 
but lipid mixing is still restricted, probably by a ring-
like complex of glycoproteins. I provide evidence that 
this state has a dynamic character and that its lipid or-
ganization can reverse back to two lipid bilayers.
Key words: rhabdovirus • prefusion complex • lipo-
some • viral fusion glycoprotein • lysophosphatidyl-
choline
 
Introduction
 
Entry of enveloped viruses into host cells requires fusion
of the viral envelope with a cellular membrane. This step is
mediated by virally encoded fusogenic glycoproteins. Acti-
vation of the fusion capacity involves structural rearrange-
ment of these proteins upon interaction with specific trig-
gers (e.g., low pH or specific receptors). It is generally
assumed that these conformational changes result in the
exposure of a fusion peptide or domain, which then inter-
acts with and destabilizes one or both of the participating
membranes.
Despite extensive work, mainly on influenza virus, the
actual mechanism of the fusion process is still unknown.
However, recent results have revealed striking similarities
between different fusion systems. Experiments performed
on viral or cellular membrane fusion have shown that
 
inverted cone-shaped lysolipids (which promote a mi-
 
cellar positive spontaneous curvature) inhibit fusion
when  present in the contacting monolayers of membranes
(Chernomordik et al., 1993, 1995; Vogel et al., 1993; Yea-
gle et al., 1994). These results have indicated that early lip-
idic fusion intermediates are similar from one system to
another and that membrane fusion may proceed via the
formation of stalk intermediates that are local lipidic con-
nections with negative curvatures between contacting
monolayers of fusing membranes (Siegel, 1993; Cherno-
mordik et al., 1995). This step would be followed by the
formation of a transient hemifusion diaphragm. Depend-
ing on the experimental system, hemifusion might be re-
stricted (i.e., without lipid flux between both membranes)
or unrestricted (i.e., without any restriction of lipid diffu-
sion). Unrestricted hemifusion has been shown to be
the final state of fusion mediated by engineered HA
ectodomain anchored into the membrane by glycophos-
phatidylinositol (GPI-HA; Kemble et al., 1994; Melikyan
et al., 1995b), whereas restricted hemifusion is encoun-
tered when HA-induced fusion is reversibly blocked at
4
 
8
 
C (Schoch et al., 1992; Chernomordik et al., 1998). Re-
striction of lipid flux has been suggested to be due to a
ring-like aggregate of HA surrounding the hemifusion dia-
phragm (Chernomordik et al., 1998). Finally, complete fu-
sion would occur by pore formation and enlargement in
the hemifusion diaphragm (Melikyan et al., 1997; Cherno-
mordik et al., 1998).
As the characteristics of the fusion pore and lipid depen-
dence of fusion appear to be similar in all biological fusion
events (Monck and Fernandez, 1992; Chernomordik et al.,
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1995), this model for membrane fusion (i.e., stalk forma-
tion followed by hemifusion and pore formation) has been
proposed to be universal. Although it is also supported by
theoretical considerations on energetics of lipidic struc-
tures (Siegel, 1993), this model is mainly based on experi-
ments performed on influenza virus hemagglutinin (HA)
 
1
 
(Chernomordik et al., 1997, 1998) and remains to be chal-
lenged in other fusion systems.
Rabies virus-induced membrane fusion is mediated by
the viral transmembrane glycoprotein (G) which is orga-
nized in trimers (three monomers of 65 kD each; Whitt
et al., 1991; Gaudin et al., 1992). The fusion properties of
rabies virus have been investigated (Gaudin et al., 1993).
Fusion is triggered at low pH, optimal around pH 5.8–6,
and is not detected above pH 6.3. Fusion of rabies virus
with liposomes is preceded by a lag time, the duration of
which increases with lower temperature and higher pH
(up to the pH threshold for fusion). Preincubation of the
virus below pH 6.75 in the absence of a target membrane
leads to inhibition of viral fusion properties. However, this
inhibition is reversible and readjusting the pH to above 7
leads to the complete recovery of the initial fusion activity.
This is the main difference between rhabdoviruses (such
as rabies virus) and other viruses fusing at low pH for
which low pH-induced fusion inactivation is irreversible
(Gaudin, 2000).
Low pH-induced conformational changes of the glyco-
protein and their relationships with fusion activity have
been studied. It has been demonstrated that G can assume
at least three different states (Gaudin et al., 1993): the na-
tive (N) state detected at the viral surface (pH 7); the
activated (A) hydrophobic state; and the fusion inactive
conformation (I). There is a pH-dependent equilibrium
between these states that is shifted toward the I state at
low pH. The A state is detected immediately after acidifi-
cation, induces the formation of viral aggregates stabilized
at low pH and low temperature (Gaudin et al., 1993), and
interacts with the target membrane as a first step of the fu-
sion process (Durrer et al., 1995). The I state is detected
after prolonged incubation at low pH. In the I conforma-
tion, G is longer than in the N conformation, but also anti-
genically distinct and more sensitive to proteases. The ex-
act role of I during the fusion process is unclear, but it has
been proposed that the role of the I state is to avoid fusion
during transport of G in the acidic Golgi vesicles (Gaudin
et al., 1995). For vesicular stomatitis virus (VSV), another
rhabdovirus, the same three states have been postulated
on the basis of kinetics studies (Clague et al., 1990; Puri
et al., 1992).
The domain of rhabdoviral G interacting with the target
membrane (the so-called fusion peptide) has been located
using hydrophobic photolabeling (Durrer et al., 1995) and
by directed mutagenesis (Li et al., 1993; Zhang and Ghosh,
 
1994; Fredericksen and Whitt, 1995, 1996). These results
have suggested that an uncharged domain of VSV G from
amino acid 118 to 136 and the homologous domain of ra-
bies virus constitute the fusion peptide of the glycoprotein.
Recent structural studies of the fusion glycoprotein of
influenza virus, retroviruses, Ebola virus, and Simian Vi-
rus 5 (a paramyxovirus) have indicated remarkable simi-
larities (Bullough et al., 1994; Fass et al., 1996; Chan et al.,
1997; Weissenhorn et al., 1997, 1998; Baker et al., 1999;
Kobe et al., 1999). All these fusion protein ectodomains
form rod-shaped 
 
a
 
-helical bundles. In the structural stud-
ies, both the COOH-terminal membrane anchor and the
NH
 
2
 
-terminal fusion peptide were removed (to have a sol-
uble molecule), but the results strongly suggest that these
peptides are colocated at one end of the rod (Skehel and
Wiley, 1998). As it has been demonstrated for the HA, this
conformation is not the metastable native conformation of
the fusion protein, but most probably represents the struc-
ture of this protein at the end of the fusion process. A
common feature of all these fusion glycoproteins is that
they are synthesized as a precursor that must be cleaved to
generate the NH
 
2
 
-terminal fusion peptide. This is not the
case for rhabdoviruses for which there is no activating
cleavage of the fusion protein. Furthermore, no coiled-coil
formation is predicted for the rhabdovirus glycoprotein
and a careful look over the amino acid sequence of G does
not reveal any obvious heptad repeats. These observa-
tions, together with the reversibility of the low pH-induced
conformational changes, suggest that rhabdoviral G may
define another category of fusogenic proteins and thus, is a
good candidate to challenge the proposed model for mem-
brane fusion.
In the present study, using a liposome assay, I have in-
vestigated the sensitivity of rabies virus-induced mem-
brane fusion to lysophosphatidylcholine (LPC) having ali-
phatic chains of varying length, and to oleic acid (OA).
The results are consistent with the fusion model proposed
for influenza virus (Chernomordik et al., 1998). The data
also indicate that under suboptimal fusion conditions the
rate limiting step for membrane fusion is the formation of
a fusion pore in a diaphragm of restricted hemifusion. Fur-
thermore, the lipidic structure in the previously described
cold-stabilized prefusion complex (Gaudin et al., 1993;
Durrer et al., 1995) was characterized. It appeared that
this intermediate is at an advanced stage of the fusion pro-
cess when a putative hemifusion diaphragm is already de-
stabilized, but lipid mixing is still restricted, most probably
by a ring-like complex of glycoproteins. This state has a
dynamic character and its lipid organization can reverse
back to two lipid bilayers. Finally, although the data sup-
port the idea that the lipidic fusion intermediates are the
same for influenza and rabies virus-induced membrane fu-
sion, they also reveal some subtle differences that will be
discussed and have to be taken into consideration for a
global understanding of virus-induced membrane fusion.
 
Materials and Methods
 
Chemicals
 
N
 
-(lissamine rhodamine B sulfonyl)-phosphatidylethanolamine (RHO-PE),
 
N
 
-(7-nitro-2,1,3-benzoxadiazol-4-yl)-phosphatidylethanolamine (NBD-
 
1
 
Abbreviations used in this paper: 
 
FIF, frozen intermediate of fusion; G,
rabies virus glycoprotein; GPI-HA; HA ectodomain linked to glyco-
sylphosphatidylinositol; HA, influenza virus hemagglutinin; LPC, lyso-
phosphatidylcholine; NBD-PE, 
 
N
 
-(7-nitro-2,1,3-benzoxadiazol-4-yl)-phos-
phatidylethanolamine; OA, oleic acid; PC, phosphatidylcholine; PE,
phosphatidylethanolamine; RHO-PE, 
 
N
 
-(lissamine rhodamine B sulfo-
nyl)-phosphatidylethanolamine; RVPC, rabies virus prefusion complex;
TMRD-3000, tetramethylrhodamine dextran with a molecular mass of
3,000.  
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PE), 1-lauroyl-2-hydroxy-sn-glycero-3-phosphocholine (lauroyl LPC),
1-myristoyl-2-hydroxy-sn-glycero-3-phosphocholine (myristoyl LPC),
1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine (palmitoyl LPC), and
1-stearoyl-2-hydroxy-sn-glycero-3-phosphocholine (stearoyl LPC) were
purchased from Avanti Polar Lipids, Inc. Phosphatidylcholine (PC; type
III-B from bovine brain), phosphatidylethanolamine (PE; type I from bo-
vine brain), gangliosides (type III from bovine brain), OA, calcein, and
tetramethylrhodamine coupled to dextran with a molecular mass of 3,000
(TMRD-3000) were supplied by Sigma-Aldrich, and 
 
L
 
-3-phosphatidyl [
 
N
 
-
methyl-
 
3
 
H]choline 1,2-dipalmitoyl ([
 
3
 
H] PC) was supplied by Amersham
Pharmacia Biotech.
 
Virus Purification
 
The PV (Pasteur Vaccine) strain was grown in BSR cells (clone of baby
hamster kidney 2l cells) at 37
 
8
 
C in MEM supplemented with 2% calf serum.
Virus particles were purified from the culture supernatant 72 h postinfec-
tion. In brief, cell debris were first eliminated by a 30-min centrifugation at
3,500 rpm in a JA14 rotor (Beckman Coulter) at 4
 
8
 
C. The virus was then
pelleted by centrifugation at 4
 
8
 
C (3 h at 14,000 rpm in a JA14) and resus-
pended in TD buffer (137 mM NaCl, 5 mM KCl, 0.7 mM Na
 
2
 
HPO
 
4
 
, 25 mM
Tris-HCl, pH 7.5). Viral purification was achieved by another centrifuga-
tion of 50 min through 30% glycerol in 10 mM Tris-HCl, pH 7.5, 50 mM
NaCl, 1 mM EDTA at 25,000 rpm in a SW 28 (Beckman Coulter) at 4
 
8
 
C.
 
Preparation of Liposomes and Assay for Fusion
 
A total of 700 
 
m
 
g of PC, 300 
 
m
 
g of PE, and 100 
 
m
 
g of gangliosides dis-
solved in organic solvents were mixed with 10 
 
m
 
g of RHO-PE and 10 
 
m
 
g of
NBD-PE and dried in vacuo. The lipidic film was suspended in 1 ml of
buffer A (150 mM NaCl, 5 mM Tris-HCl, pH 8) and the mixture was bath-
sonicated for 20 min. Liposomes were used within 3 d.
Fusion was assayed as previously described by using the resonance en-
ergy transfer method of Struck et al. (1981). If not indicated otherwise, all
fusion experiments were performed at 22
 
8
 
C. 10 
 
m
 
l of fluorescent lipo-
somes were mixed with 980 
 
m
 
l of phosphate-citrate buffer at the required
pH (prepared from 100 mM citric acid and 200 mM dibasic sodium phos-
phate solution) in the cuvette of a thermostated Perkin-Elmer LS50B
spectrofluorimeter. Then, 10 
 
m
 
l of virus (
 
z
 
50 
 
m
 
g of viral proteins) was
added and the increase of NBD fluorescence was monitored continuously.
In this range of viral concentrations, the increase of NBD fluorescence
was proportional to the viral concentration and thus to the number of fu-
sion events. Excitation was at 455 nm (slit width, 4 nm) and emission was
at 535 nm (slit width, 10 nm). The mixture was kept under continuous stir-
ring during the experiments.
For studies on the prefusion complex, 10 
 
m
 
l of virus (50 
 
m
 
g of viral pro-
teins) were incubated with 10 
 
m
 
l of liposomes and 20 
 
m
 
l of phosphate-
citrate buffer, pH 6.45, on ice for the indicated duration, and the mixture
was diluted in the spectrofluorimeter cuvette in 960 
 
m
 
l of phosphate-
citrate buffer at the required pH.
Experiments performed with the same viral stocks, same liposome
preparations, and same buffers were highly reproducible (fusion extent
variations were 
 
,
 
5%). However, the extent and kinetics of fusion under
suboptimal pH conditions (pH 6.2) were variable when different viral
stocks, liposomes preparations, or buffer (pH buffer could vary within 
 
6
 
0.02 pH units) were used. Experiments presented here were repeated at
least three times and all qualitative results reported in this paper were ob-
served in each experiment.
 
Leakage Measurements
 
Calcein was encapsulated into liposomes by hydrating the lipid film in
buffer containing 40 mM calcein, 80 mM NaCl, 2 mM EDTA, 5 mM Tris-
HCl, pH 8 (calcein was dissolved by addition of 
 
z
 
120 mM NaOH in the
buffer). TMRD-3000 was encapsulated by hydrating the lipid film in
buffer A containing 20 mg/ml of the dye. After sonication, free dyes were
removed by molecular sieve chromatography on sephadex G-75 equili-
brated with buffer A (containing 2 mM EDTA when calcein was used).
Relief of self-quenching due to dilution of the dye upon leakage was mea-
sured by monitoring calcein fluorescence at 520 nm with excitation at
490 nm (slit width 2.5 nm) and TMRD-3000 fluorescence at 580 nm with
excitation at 530 nm (slit width 5 nm). The measurements were carried out
in buffer A (containing 2 mM EDTA when calcein-loaded liposomes were
used). The initial fluorescence intensity of TMRD-3000 or calcein-loaded
liposomes was set to zero.
 
Inhibition of Fusion By LPC and OA
 
Stock solutions of lauroyl (5 mM), myristoyl (1 mM), and palmitoyl (1 mM)
LPC were freshly prepared as aqueous dispersions. Stock solution of
stearoyl LPC (1 mM) and OA (1 mM) were freshly prepared as ethanolic
solutions. In fusion experiments, the lipids were added into the cuvette
containing the liposomes diluted in phosphate-citrate buffer at the re-
quired pH 2 min before addition of the virus. This time was largely suffi-
cient to reach the equilibrium of their partition between the aqueous me-
dium and the liposome membrane as judged by the increase of NBD
fluorescence (due to exogenous lipid incorporation), which had reached a
plateau after a few seconds (see Fig. 2 A).
The increase of NBD fluorescence due to lipid incorporation into the
liposomes was used to estimate the amount of lipid incorporated. To eval-
uate how various dilutions of NBD-PE and RHO-PE affect the extent of
NBD-PE fluorescence, a 1:1 (wt/wt) mixture of NBD-PE and RHO-PE
was diluted into different amounts of a 7:3:1 (wt/wt/wt) mixture of PC, PE,
and gangliosides in organic solvents. Liposomes were then made as de-
scribed in the previous paragraph. Fluorescence of NBD was measured
before (F) and after (F
 
0
 
) 0.8% Triton X-100 addition. A plot of F
 
0
 
/F ver-
sus the fluorescent probe dilution gave a calibration curve that was used to
estimate the incorporation of lipids in the liposomes. This approach as-
sumes that the fluorescent probes and the added lipids are homoge-
neously and independently distributed in the liposome membrane.
 
Liposome Binding to Virus
 
For these experiments, liposomes were made as described above, but con-
tained 40 
 
m
 
Ci of [
 
3
 
H] PC per mg of lipid. For binding experiments, 15 
 
m
 
l of
liposomes were mixed with 75 
 
m
 
l of phosphate-citrate buffer at pH 6.45 or
150 mM NaCl, 50 mM Tris-HCl, pH 8, and 10 
 
m
 
l of virus (50 
 
m
 
g of viral
proteins). The mixture was incubated for 3 min on ice, layered onto a cold
25% glycerol solution in 150 mM NaCl, 50 mM Tris-HCl, pH 8, or in phos-
phate-citrate buffer pH 6.45, and then centrifuged for 30 min at 40,000
rpm in an SW55 rotor (Beckman). The amount of liposomes associated
with virus in the pellet was determined by liquid scintillation counting. To
study their effect on liposome binding to virus, exogenous lipids were
added to the mixture before addition of the virus.
 
Results
 
Effect of LPC on Rabies Virus-induced
Membrane Fusion 
 
Altering membrane lipid composition by addition of lipids
that affect the curvature of lipid monolayers has been used
to study the different stage of membrane fusion (Cherno-
mordik et al., 1993, 1997; Vogel et al., 1993; Yeagle et al.,
1994). Of particular interest are the inverted cone-shaped
LPC that promote a micellar positive spontaneous curva-
ture, and the cone-shaped cis-unsaturated fatty acids that
promote inverted hexagonal H
 
II
 
 phase. Thus, stalk forma-
tion should be promoted by cis-unsaturated fatty acids and
inhibited by LPC when these lipids are present in the
outer leaflet of the membranes. On the other hand, pore
formation and expansion should be promoted by LPC and
inhibited by cis-unsaturated fatty acids when these lipids
are present in the inner leaflet of the membranes (Cherno-
mordik et al., 1998).
The dependence of fusion on the presence of various
concentrations of LPC with saturated aliphatic chains of
varying lengths (from 12 to 18 hydrocarbon groups) was
studied. Under optimal fusion conditions (pH 5.85), the
extent of fusion decreased in a dose dependent manner
(Figs. 1 and 2 D). The LPC concentrations used in these
experiments did not solubilize the liposomes: as shown in
Fig. 2 A, upon LPC addition, an increase of NBD fluores-
cence was observed that was much slighter than the in-
crease of NBD fluorescence upon addition of solubilizing 
The Journal of Cell Biology, Volume 150, 2000 604
 
concentrations of Triton X-100 (0.8%). This slight in-
crease of NBD fluorescence was due to incorporation of
LPC into the membrane of the liposomes resulting in dilu-
tion of RHO-PE and NBD-PE, and consequently in a de-
crease of the transfer energy efficiency.
Potential leakage induced by LPC was also investigated.
For palmitoyl (C16) and stearoyl (C18) LPC, no leakage
was observed when fusion-inhibiting concentrations were
used. For these lysolipids, three to four times higher con-
centrations than those used in the inhibition experiments
were necessary for the encapsulated dyes to leak out (Fig.
2, B and C). A slight leakage of TMRD-3000, occurring
much slower than in the presence of solubilizing concen-
trations of LPC, was detected when fusion-inhibiting con-
centrations of lauroyl (C12) and myristoyl (C14) LPC
were used (Fig. 2 C). This leakage was not detected when
calcein-loaded liposomes were used (although calcein is
smaller than TMRD-3000), but slight increase of calcein
fluorescence could have been hidden by the noisy signal
(Fig. 2 B). Taken together, these control experiments indi-
cated that the inhibitory effect of LPC was neither due to
solubilization nor to lysis of liposomes.
As in other systems (Chernomordik et al., 1997), the in-
hibiting concentrations were dependent on the length of
the hydrocarbon chains: LPC with longer chains have an
inhibiting effect at lower concentrations (Figs. 1 and 2 D,
Table I). However, as it is well documented that partition-
ing of LPCs into membranes increases with their hydro-
phobicity (i.e., with their hydrocarbon chain length), the
concentration of LPC in the membranes was evaluated us-
ing NBD dequenching (due to LPC incorporation into the
membrane), and the calibration curve was obtained as de-
scribed in Materials and Methods. Estimates of the mem-
brane concentrations required to cause 50% inhibition of
fusion are indicated in Table I. It appeared that LPC with
shorter hydrocarbon chains (and thus a more pronounced
inverted cone shape) required lower membrane concen-
trations to inhibit fusion.
Under suboptimal fusion conditions (pH 6.2), palmitoyl
(C16) and stearoyl LPC (C18) were still inhibiting fusion
in a dose dependent manner at concentrations similar to
those inhibiting fusion at pH 5.85 (Fig. 3). However, al-
Figure 1. Inhibition of rabies virus-induced fusion by LPC under
optimal fusion conditions. Fusion was assayed at pH 5.85 and
228C. Effects of increasing concentrations of lauroyl (C12),
myristoyl (C14), palmitoyl (C16), and stearoyl (C18) LPC on fu-
sion between rabies virus and fluorescent liposomes containing
NBD-PE and RHO-PE. The increase of NBD fluorescence was
measured as described in Materials and Methods. Fluo., Fluores-
cence; A.U., arbitrary units.
Figure 2. A, Concentrations of LPC that inhibit fusion do not
solubilize liposomes. 10 ml of fluorescent liposomes were mixed
with 990 ml of buffer A in the cuvette of the spectrofluorimeter.
The initial fluorescence intensity of NBD was set to zero. Lauroyl
(C12; 300 mM), myristoyl (C14; 30 mM), palmitoyl (C16; 8 mM),
or stearoyl (C18; 8 mM) LPC were added (at t 5 0 s) in the
cuvette. When the equilibrium was reached, membranes were
solubilized with Triton X-100 (0.8%). The increase of NBD fluo-
rescence after Triton X-100 addition was normalized to 100. B,
LPC-induced leakage of calcein-loaded liposomes. Liposomes
(final concentration, 10 mg/ml of phospholipids) were mixed with
buffer A (supplemented with 2 mM EDTA) in the cuvette of the
spectrofluorimeter. The initial fluorescence intensity of calcein
was set to zero and lauroyl (C12), myristoyl (C14), palmitoyl
(C16), or stearoyl (C18) LPC were added (at t 5 0 s) in the cu-
vette at the indicated concentrations. C, LPC-induced leakage of
TMRD-3000–loaded liposomes. Liposomes (final concentration,
10 mg/ml of phospholipids) were mixed with buffer A in the cu-
vette of the spectrofluorimeter. The initial fluorescence intensity
of TMRD-3000 was set to zero and lauroyl (C12), myristoyl
(C14), palmitoyl (C16) or stearoyl (C18) LPC were added (at t 5
0 s) in the cuvette at the indicated concentrations. D, Inhibition
of rabies virus-induced fusion by LPC under optimal fusion con-
ditions. The extent of fusion at pH 5.85 and 228C, assayed by the
increase of NBD fluorescence, was plotted versus the total con-
centration of lauroyl (h), myristoyl (s), palmitoyl (n), and
stearoyl (j) LPC in the medium. The 100% fusion activity was
measured in absence of LPC. The graph shows the mean of five
experiments like the one shown in Fig. 1. Error bars indicate SD. 
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though still inhibiting fusion at high concentrations, lau-
royl (C12) and myristoyl (C14) LPC increased the number
of fusion events at low concentrations (Fig. 3). Further-
more, in the presence of lauroyl and myristoyl LPC, the
lag time preceding fusion at pH 6.2 disappeared and the
initial kinetics of fusion were faster.
The simplest explanation of these first results is that in-
corporation of LPC in the outer leaflet of the membranes
resulted in inhibition of stalk formation as demonstrated
by the results obtained at pH 5.85. Furthermore, Fujii et al.
(1985) have shown that the rate of transbilayer movement
of LPC increases with decreasing acyl chain length (consis-
tently with the slight leakage of liposomes observed in the
presence of lauroyl and myristoyl LPC; Fig. 2 C), the re-
sults obtained at pH 6.2 strongly suggest that lauroyl and
myristoyl LPC, but not palmitoyl or stearoyl LPC, were
translocated in the inner leaflet and thus were present in
both monolayers. Indeed, the presence of lauroyl and
myristoyl LPC in the inner leaflet would promote pore
formation and expansion, and would explain the increase
in fusion extent, together with the faster kinetics of fusion.
Finally, at pH 6.2, the lag time preceding fusion was no
longer detected in the presence of lauroyl and myristoyl
 
LPC. This indicates that this lag time is not due to slow
binding of the virions to the liposomes, but rather that the
rate limiting step of fusion under suboptimal conditions is
the formation and the expansion of a fusion pore in a
hemifusion diaphragm.
 
LPC Does Not Inhibit Fusion Peptide Insertion in the 
Target Membrane 
 
Although the inhibiting effect of LPC on rabies virus-
induced membrane fusion could be explained by their ef-
fect on the outer monolayer curvature, it was also possible
that part of their inhibiting action was due to binding to
the hydrophobic fusion peptide which could then no
longer insert into the target membrane. Such a mechanism
for LPC-induced fusion inhibition has been proposed for
the case of HIV gp120/gp41-mediated fusion (Günther-
Ausborn and Stegmann, 1997).
Thus, a potential inhibition of rabies virus binding to
target liposomes was investigated. For this, rabies virus
was incubated for three minutes at pH 6.45 and 0
 
8
 
C with li-
posomes containing tritiated PC in the presence of LPCs.
Under these conditions, although no fusion is detected,
the virions interact in a hydrophobic manner with the tar-
get membrane via their fusion peptides. These conditions
previously have been defined as prefusion conditions
(Gaudin et al., 1993; Durrer et al., 1995). After incubation,
the mixture was centrifuged through a 30% glycerol cush-
ion, above which unbound liposomes were floating, and
the radioactivity associated with the virus in the pellet was
assayed by liquid scintillation counting. The results are
presented in Fig. 4. They show that the presence of 300 
 
m
 
M
lauroyl, 30 
 
m
 
M myristoyl, 10 
 
m
 
M palmitoyl, or 10 
 
m
 
M
stearoyl LPC was without effect on virus binding to the li-
posomes, indicating that it was indeed their ability to in-
duce a micellar positive curvature of the outer leaflet,
which was responsible for their ability to inhibit fusion.
 
Effect of OA on Rabies Virus-induced
Membrane Fusion 
 
The effect of cone-shaped lipids on fusion was then stud-
ied, and liposomes were incubated with various OA con-
centrations before addition of the virus. The effect of OA
was dependent on pH. At pH 6.2, OA inhibited the fusion
reaction. A concentration of 5 
 
m
 
M OA decreased the ex-
 
Table I. Total and Membrane LPC Concentrations Giving 50% 
Fusion Inhibition
 
LPC
Total LPC concentration 
giving 50% fusion inhibition
Membrane concentration of LPC 
giving 50% fusion inhibition
 
m
 
M%
 
Lauroyl 240 
 
6 
 
50 4.1 
 
6 
 
0.5
Myristoyl 23 
 
6 
 
2 5.8 
 
6 
 
0.5
Palmitoyl 6.5 
 
6 
 
1 8.7 
 
6 
 
2
Stearoyl 4.1 
 
6 
 
2 9.9 
 
6 
 
2
 
The total LPC concentration in the medium giving 50% of fusion inhibition was
calculated from the graph in Fig. 2. The amount of LPC incorporated in the membrane,
and thus the membrane concentration of LPC giving 50% of inhibition, were calculated
as indicated in Materials and Methods.
Figure 3. Inhibition and pro-
motion of rabies virus-induced
fusion by LPC under subop-
timal fusion conditions. Fu-
sion was assayed at pH 6.2
and 228C. Effects of increas-
ing concentrations of lau-
royl (C12), myristoyl (C14),
palmitoyl (C16), and stearoyl
(C18) LPC on fusion be-
tween rabies virus and fluo-
rescent liposomes containing
NBD-PE and RHO-PE. The
increase of NBD fluores-
cence was measured as de-
scribed in Materials and
Methods. Fluo., Fluores-
cence; A.U., arbitrary units.
Figure 4. Exogenous lipids do
not inhibit insertion of the fu-
sion peptide in the target
membrane. Virions were in-
cubated for 3 min on ice with
tritiated liposomes at pH 8 or
at pH 6.45 in absence or in the
presence of the indicated ex-
ogenous lipids concentration.
The mixture was centrifuged
as described in Materials and
Methods, and the amount of liposomes associated with virus in the
pellet was determined by liquid scintillation counting. The graph
shows the mean of three independent experiments. Error bars in-
dicate SD. The value of radioactivity associated with the virus at
pH 6.45 in absence of exogenous lipids was defined as 100%, and
the other values were calculated as percentages thereof. 
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tent of fusion by a factor of 2.5 and a concentration of 10 
 
m
 
M
virtually completely inhibited fusion (Fig. 5, pH 6.2). At
lower pH, OA was much less inhibiting, and at pH 5.85
(Fig. 5), a concentration of 20 
 
m
 
M of OA was without ef-
fect on the fusion reaction. Potential inhibition of virus–
liposome binding by OA was also assayed. Again (Fig. 4)
it was shown that under prefusion conditions, OA was
without effect on virus binding to the liposomes. Thus, as
OA is known to be easily translocated in the inner leaflet
(Broring et al., 1989), inhibition of the fusion reaction un-
der suboptimal fusion conditions was probably due to inhi-
bition of pore formation and expansion in the hemifusion
diaphragm.
 
Compensation of the Inhibiting Effect of LPC by 
Addition of OA 
 
The inhibiting effect of LPC at pH 5.85 could be compen-
sated at least partially by addition of OA into the mem-
branes (Fig. 6). The compensatory effect was stronger with
palmitoyl and stearoyl LPC (Fig. 6, B and C), but was still
detected with myristoyl LPC (Fig. 6 A). No compensatory
effect of OA on fusion inhibition by lauroyl LPC was ob-
served. However, presence of OA affected the incorpora-
tion of lauroyl LPC into the membranes as judged by the
larger increase of NBD fluorescence (data not shown).
These results are in agreement with the additivity of
lipid effects on the spontaneous curvature of lipid mono-
layer (Madden and Cullis, 1982), and reinforce the idea
that the inhibiting effect of LPC is due to its ability to in-
duce a positive curvature of the outer membrane leaflet.
 
Structure of the Prefusion Complex
 
As mentioned above, we have previously demonstrated
the existence of a stable prefusion complex (Gaudin et al.,
1993; Durrer et al., 1995) that is formed when the virus is
preincubated between pH 6.3 and 6.7 with liposomes on
ice. The kinetics of formation of the rabies virus prefusion
complex (RVPC) at pH 6.45 and 0
 
8
 
C were investigated
(Fig. 7). Virions were incubated for increasing periods in
the presence of liposomes at pH 6.45 and 0
 
8
 
C. The mixture
was then diluted in the spectrofluorimeter cuvette contain-
ing a pH 6.2 phosphate-citrate buffer at 22
 
8
 
C. In the ab-
sence of this preincubation step, the fusion curve at pH 6.2
and 22
 
8
 
C had a typical sigmoidal shape and the increase of
NBD fluorescence was preceded by a lag time of 
 
z
 
30 s
(Fig. 7, but also see Fig. 2). Preincubation of the virus with
the liposomes at pH 6.45 and 0
 
8
 
C resulted in faster fusion
kinetics, disappearance of the lag time, and increase of fu-
sion extent. A significant modification of the aspect of the
fusion curve was already detected after a 20 s preincuba-
tion (Fig. 7), and the effect was maximal after 
 
z
 
2 min as
longer preincubations did not result in faster fusion kinet-
ics or larger increase of fusion extent (data not shown).
As LPCs were able to arrest fusion after hydrophobic
interaction of the glycoprotein, but before lipid mixing, it
was interesting to test the effect of LPC on fusion once
RVPC is made. For this, virions were incubated with lipo-
Figure 5. Inhibition of ra-
bies virus-induced fusion by
OA under suboptimal fusion
conditions. Effects of in-
creasing concentrations of
OA on fusion between rabies
virus and fluorescent lipo-
somes containing NBD-PE
and RHO-PE at pH 5.85 and
pH 6.2. The increase of NBD
fluorescence was measured
as described in Materials and
Methods. Fluo., Fluores-
cence; A.U., arbitrary units.
Figure 6. LPC and OA com-
pensate the effects of each
other on rabies virus-induced
fusion. Fusion was assayed at
pH 5.85 and 228C. Myristoyl
(A), palmitoyl (B), and
stearoyl (C) LPC were added
at the indicated concentra-
tions into the cuvette con-
taining the liposomes 1 min
before addition of OA and 2
min before addition of the vi-
rus. The increase of NBD
fluorescence was measured
as described in Materials and
Methods. Fluo., Fluores-
cence; A.U., arbitrary units.
Figure 7. Kinetics of forma-
tion of the prefusion com-
plex. Fusion was assayed at
pH 6.2 and 228C after prein-
cubation of the virus with the
liposomes at pH 6.45 and 08C
for the indicated durations,
as described in Materials and
Methods. Fluo., Fluores-
cence; A.U., arbitrary units. 
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somes at 0
 
8
 
C, either at pH 6.45 or 7.4 for three minutes.
The prefusion complex was made at pH 6.45, but not at
pH 7.4. The mixture was then diluted in the spectrofluo-
rimeter cuvette containing phosphate-citrate buffer at pH
5.85 in the presence or absence of 10 
 
m
 
M LPC (palmitoyl
or stearoyl LPC). After a preincubation of the virions and
the liposomes at pH 7.4, lipid mixing was still sensitive to
LPC (Fig. 8, pH 7.4), whereas when the prefusion complex
was previously formed at pH 6.45 and 0
 
8
 
C, lipid mixing
was then largely insensitive to LPC (Fig. 8, pH 6.45). The
results of these experiments indicated that at pH 6.45 and
0
 
8
 
C, fusion is blocked at a stage downstream of the palmi-
toyl and stearoyl LPC-sensitive stage.
Finally, the disappearance of the lag time at pH 6.20 in-
dicates that once RVPC is made, most of the events pre-
ceding lipid mixing have already occurred. As experiments
performed with lauroyl and myristoyl LPC have indicated
that the rate limiting step of the fusion process at pH 6.2
could be the formation of a fusion pore and its expansion
in a hemifusion diaphragm, this suggests that at pH 6.45
and 0
 
8
 
C, fusion is blocked at a well-advanced stage when a
putative hemifusion diaphragm is already destabilized, but
lipid mixing is still restricted.
 
Merger of Membranes Inside RVPC Is Reversible
 
As already demonstrated (Gaudin et al., 1993; Durrer et al.,
1995), a second protonation step lowering the pH below
6.3 is necessary to induce the transition from the RVPC
state to complete fusion. Indeed, incubation of RVPC at
pH 6.45 and temperature above 20
 
8
 
C did not induce any
increase of NBD fluorescence (data not shown). Further-
more, after incubation of RVPC at pH 6.45 and 30
 
8
 
C (Fig.
9 A), the rate and the extent of fusion induced at pH 6.2
were lower than the rate and extent observed when RVPC
was directly diluted at pH 6.2 (i.e., when virions and lipo-
somes were only preincubated for three minutes at pH
6.45 and 0
 
8
 
C), indicating a progressive disruption of
RVPC under such conditions.
Similar results were obtained when RVPC was treated
with proteinase K at pH 6.45 and 0
 
8C (Fig. 9 B). Thus, pro-
teolysis of G also resulted in breaking RVPC without in-
ducing complete fusion (as a control, dilution of RVPC in
the fluorimeter cuvette thermostated at 08C containing
phosphate-citrate buffer at pH 6.45 and proteinase K did
not induce any fluorescence increase).
These results indicate that the transition from RVPC to
complete fusion is still a glycoprotein-dependent process
and that local membrane merger (and maybe even initial
pore formation in a restricted hemifusion diaphragm) is not
sufficient to allow spontaneous complete fusion of mem-
brane lipid bilayers. The corollary is that fusion pore ex-
pansion is still a high-cost energy step.
As disruption of RVPC resulted in the lipid organiza-
tion reversing back to two lipid bilayers, it was interesting
to see the effect of prolonged incubation of RVPC at pH
6.45 and 08C in the presence of LPC. In fact, since LPC
should not support the curvature adopted by the external
lipid monolayer in RVPC, LPC should dissociate the con-
nections between the outer leaflets of target and viral
membranes. This was indeed the case as incubation of
RVPC for 30 s in the presence of palmitoyl LPC signifi-
cantly decreased the rate and the extent of fusion induced
at pH 6.2, and longer incubations (15 min) resulted in
complete fusion inactivation (Fig. 10 A). It was important
to control that this effect was not due to slow glycoprotein
extraction from viral particles. For this purpose, virus and
liposomes were incubated with the same concentration of
palmitoyl LPC as in Fig. 10 A for 10 min. This treatment
resulted in complete inhibition of fusion after dilution of
the mixture in the cuvette (final pH was 6.1; Fig. 10 B,
curve LPC). However, when BSA was added to the mix-
ture before triggering fusion, the integrity of the fusion ac-
tivity was recovered (Fig. 10 B, curve LPC 1 BSA). This
indicated that BSA was able to extract LPC from the
membranes and that no LPC-induced solubilization of the
viral glycoproteins occurred during the experiment.
As a conclusion, in RVPC, although fusion is blocked at
a stage downstream the LPC-sensitive stage (Fig. 8), the
Figure 8. In RVPC, fusion is
blocked at a stage subse-
quent to the LPC-sensitive
stage. Virions and liposomes
were incubated for 3 min on
ice at pH 6.45 or 7.4 before
dilution in the spectrofluo-
rimeter cuvette containing
phosphate-citrate buffer at
pH 5.85 in the absence or
presence of 10 mM palmitoyl
or stearoyl LPC. The prefu-
sion complex was made at
pH 6.45, but not at pH 7.4.
Fluo., Fluorescence; A.U.,
arbitrary units.
Figure 9. A, RVPC is dis-
rupted by incubations at pH
6.45 and 308C. Virions and li-
posomes were incubated for
3 min on ice at pH 6.45. The
mixture was then diluted di-
rectly (RVPC), or after a 1-
or 2-min incubation at 308C
(RVPC 1 min 308C; RVPC 2
min 308C, respectively), in
the spectrofluorimeter cu-
vette containing phosphate-
citrate buffer at pH 6.2 and
228C. The last curve (No pre-
inc.) corresponds to fusion at
pH 6.2 and 228C in absence
of a preincubation with the
liposomes at pH 6.45 on ice. B, RVPC is disrupted by proteinase
K treatment. Virions and liposomes were incubated for 3 min on
ice at pH 6.45. The mixture was then diluted directly (RVPC) or
after a proteinase K treatment at pH 6.45 and 08C as indicated, in
the spectrofluorimeter cuvette containing phosphate-citrate
buffer at pH 6.2 and 228C. The last curve (No preinc.) corre-
sponds to fusion at pH 6.2 and 228C in absence of a preincubation
with the liposomes at pH 6.45 on ice.The Journal of Cell Biology, Volume 150, 2000 608
lipid organization is still sensitive to prolonged incubations
in the presence of LPC. This reveals the dynamic character
of this fusion intermediate and confirms that this stage can
still reverse back to two membranes.
Discussion
Lipids of different shape, such as lysolipids or cis-unsatur-
ated fatty acids, have proved to be useful tools to study the
structural intermediates occurring during the fusion pro-
cess (Chernomordik et al., 1993, 1995, 1997, 1998; Vogel
et al., 1993; Yeagle et al., 1994). In the present study, I
have used LPC and OA to determine the rabies virus-
induced fusion pathway. The effects of these lipids on ra-
bies virus-induced fusion are similar to those observed in
other fusion systems and reinforce the idea that the fusion
pathway is the same in all biological fusion events.
LPC Incorporated in the Outer Leaflet of Membranes 
Inhibits Rabies Virus-induced Membrane Fusion 
Consistently with the Stalk Hypothesis 
Under optimal fusion conditions (pH 5.85), LPCs with ali-
phatic chains having 12–18 hydrocarbon groups inhibit fu-
sion in a range of inhibitory concentrations in solution that
is similar to that observed for the influenza virus (Cherno-
mordik et al., 1997). This result is in agreement with the
predictions of the stalk model for fusion as presence of
LPC in the outer leaflet would inhibit stalk formation
(Chernomordik et al., 1999). However, the mechanism of
LPC inhibition of fusion is often debated. Particularly, one
alternative interpretation is that LPC directly binds to the
fusion peptide of fusogenic glycoproteins and inhibits its
interaction with the target membrane (Günther-Ausborn
and Stegmann, 1997). The results presented here rule out
this hypothesis for rabies virus as the presence of LPC
does not inhibit virus binding to liposomes under prefu-
sion conditions. Furthermore, addition of OA was found
to compensate the inhibitory effect of LPC in agreement
with its complementary cone shape. This result indicates
that it is membrane-incorporated LPC rather than LPC in
solution that is responsible for fusion inhibition. Finally, as
for the influenza virus, it appears that although the aque-
ous concentration of lauroyl LPC giving a twofold inhibi-
tion is z60 times higher than that of stearoyl LPC, the cor-
responding membrane concentration of lauroyl LPC is
two times lower than that of stearoyl LPC. As lauroyl LPC
has a more pronounced inverted cone shape, here again,
this result is consistent with the stalk hypothesis.
In the case of influenza virus-induced fusion, presence
of OA in the outer leaflet of the fusing membranes pro-
moted fusion, presumably because it promoted stalk for-
mation (Chernomordik et al., 1997). Interestingly, rabies
virus-induced fusion was not promoted in the presence of
OA (except when LPC was added previously in the mem-
branes). This suggests that stalk formation is an efficient
process in this fusion system, which cannot be further en-
hanced by presence of OA in the outer leaflet. This differ-
ence with the influenza virus may be due to intrinsic prop-
erties of the fusion machinery of both viruses. However, it
may also be due to the different experimental procedures,
as Chernomordik et al. (1997) were working with cells ex-
pressing HA fusing with red blood cells, whereas I used vi-
ruses fusing with liposomes. Both the density of fusogenic
glycoproteins (much higher at the viral surface) and differ-
ent constraints on cellular and liposomal membranes may
explain this difference of efficiency in stalk formation.
Rabies Virus Induced-membrane Fusion Proceeds Via 
the Formation of a Lipidic Pore in a
Hemifusion Diaphragm
Another critical issue for fusion mediated by a protein ma-
chinery is the nature of the fusion pore: is it a proteina-
ceous pore whose expansion leads to lipid merger (Lindau
and Almers, 1995) or a lipidic pore in a hemifusion dia-
phragm (Zimmerberg et al., 1993; Kemble et al., 1994; Me-
likyan et al., 1995b, 1997; Chernomordik et al., 1998)? In
general, inhibition of fusion by membrane-incorporated
LPC is considered as a strong argument in favor of the lat-
ter hypothesis (Chernomordik et al., 1998, 1999), but two
other observations presented here are also consistent with
a lipidic nature of the fusion pore.
First, under suboptimal fusion conditions, OA, which is
known to be translocated in the inner leaflet (Broring et al.,
1989), inhibits fusion as expected from a cone-shaped lipid
promoting negative curvature of the inner leaflet. Second,
one striking and unexpected result was the disappearance
of the lag time preceding fusion and the faster kinetics of
fusion in the presence of lauroyl and myristoyl LPC under
suboptimal fusion conditions (pH 6.20). This demonstrates
Figure 10. A, RVPC is dis-
rupted by prolonged incuba-
tion in the presence of LPC.
Virions (50 mg of viral pro-
teins) and liposomes were in-
cubated for 3 min on ice at
pH 6.45. The mixture was
then diluted in 150 mM NaCl
(final volume 500 ml, concen-
tration of phospholipids 20
mg/ml) containing palmitoyl
LPC (final concentration 25
mM) and kept on ice for indi-
cated times before a two-
time dilution in the spectro-
fluorimeter cuvette containing
phosphate-citrate buffer pH
6.2 at 228C (in the cuvette the concentration of liposomal phos-
pholipids and of palmitoyl LPC was 10 mg/ml and 12.5 mM, respec-
tively). As a control (No LPC), the mixture of virions and lipo-
somes was diluted in 150 mM NaCl containing no LPC and kept
on ice for 15 min before dilution in the spectrofluorimeter cu-
vette. B, LPC does not extract glycoproteins from viral mem-
brane. Virions (50 mg of viral proteins) and liposomes were
mixed in buffer A (final volume 500 ml, concentration of phos-
pholipids 20 mg/ml) in the absence (No treatment) or presence
(LPC) of palmitoyl LPC (final concentration 25 mM) and kept on
ice for 10 min before a two-time dilution in the spectrofluorime-
ter cuvette containing phosphate-citrate buffer pH 6.1 at 228C.
The last curve (LPC 1 BSA) corresponds to virions and lipo-
somes mixed in buffer A, kept on ice for 10 min in the presence
of palmitoyl LPC, and subsequently incubated on ice with BSA
(2.5 mg/ml) for 10 min before a two-time dilution in the spectro-
fluorimeter cuvette containing phosphate–citrate buffer pH 6.1 at
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that the events preceding membrane continuity were sen-
sitive to the shape of the lipids present in the membranes.
Thus, the lag time detected before the onset of fusion was
not due to slow binding of the virions to the liposomes, but
rather to slow reorganization of the lipids in the fusion
complex. The faster fusion kinetics were not observed with
LPC having longer hydrocarbon chains. As the rate of
transbilayer movement of LPC increases with decreasing
acyl chain length (Fujii et al., 1985) consistently with the
results presented here on LPC-induced leakage, this sug-
gests that lauroyl and myristoyl LPC were translocated in
the inner leaflet and, in agreement with the lipidic pore
model, would promote pore formation in a hemifusion di-
aphragm. Thus, the fusion enhancement observed at low
concentrations of lauroyl and myristoyl LPC under subop-
timal conditions is probably due to an increased propor-
tion of hemifusion diaphragms that transformed into com-
plete fusion although less stalks were made. Finally, the
disappearance of the lag time in the presence of lauroyl
and myristoyl LPC indicates that the rate limiting step for
fusion under suboptimal conditions would be the forma-
tion of a fusion pore and its enlargement into a hemifusion
diaphragm.
In the Prefusion Complex, the Hemifusion Diaphragm 
Is Already Destabilized, but Lipid Mixing Is
Still Restricted
Previously, we had demonstrated that when viruses and li-
posomes are preincubated at slightly acidic pH (between
pH 6.4 and 6.7) and 08C, although no membrane continu-
ity is detected, rabies virions bind to the liposomes in a hy-
drophobic manner and their fusion peptides are inserted
in the target membrane (Gaudin et al., 1993; Durrer et al.,
1995). Here, the structure of this RVPC was investigated.
The results indicated that once RVPC is made, most of
the events preceding membrane continuity are already
achieved. In fact, arguments presented in the results sec-
tion suggest that in RVPC, fusion is blocked at an ad-
vanced stage when a fusion pore is already present in the
hemifusion diaphragm, but lipid mixing is still restricted.
Restriction of lipid diffusion was first demonstrated in
HA-induced membrane fusion (Chernomordik et al.,
1998). This restriction is supposed to be due to the forma-
tion of a ring-like complex made of several low pH-acti-
vated HA (Blumenthal et al., 1996; Danieli et al., 1996). In
the case of the rhabdoviruses, it has been shown that more
than one trimer of G is required to build a competent fu-
sion site (Bundo-Morita et al., 1988; Gaudin et al., 1993).
Furthermore, we have recently described two rabies mu-
tants with mutations in their glycoprotein for which the
conformational change toward the inactivated state is con-
siderably slowed down. Interestingly, these mutants pre-
sented an unexpected phenotype: they showed a hexago-
nal lattice of G at their surface under prefusion conditions
(pH 6.6 and 08C). Each angle of a hexagon seemed to be
made up by a trimer of G and the lattice was not observed
when spikes in the inactivated conformation were de-
tected (Gaudin et al., 1996). We have proposed that one
hexagon, once associated with a target membrane, consti-
tutes a minimal prefusion complex for rabies virus (Gau-
din et al., 1999). If this is true, diffusion of the lipids inside
this hexagon might be restricted either by the transmem-
brane domains or by membrane-inserted fusion peptides
of the activated glycoproteins making up a hexagon. The
fact that, in photolabeling experiments performed under
prefusion conditions (6.4 and 08C), labeling was found
only in the fusion peptide and not in the transmembrane
domain (Durrer et al., 1995) suggests that lipid diffusion is
restricted by fusion peptides inserted in the target mem-
brane. This could also be the case for influenza virus be-
cause GPI-HA lacking HA transmembrane domain has been
shown to induce restricted hemifusion under suboptimal
fusion conditions (Chernomordik et al., 1998).
The properties of RVPC resemble those of the so-called
frozen intermediate of fusion (FIF; also called committed
state) observed for influenza HA-induced fusion (Schoch
et al., 1992; Chernomordik et al., 1998). However, it has
been shown that FIF is a restricted hemifusion that pre-
cedes fusion pore formation (Chernomordik et al., 1998),
whereas the kinetics presented here suggest that pore for-
mation has already occurred in RVPC. In fact, the lipidic
organization in RVPC is probably similar to the structure
of the flickering pore observed in influenza virus-induced
fusion (Melikyan et al., 1993, 1995a; Tse et al., 1993; Zim-
merberg et al., 1994), which is also a dynamic intermediate.
Reversibility of Membrane Merger at the
RVPC-arrested Stage
In the case of influenza HA-induced membrane fusion, once
FIF is made, fusion can be achieved at pH 7.4 and 378C. This
is not the case with RVPC for which a second protonation
step (occurring below pH 6.3) is absolutely required for fu-
sion to be triggered. In fact, increasing the temperature with-
out lowering the pH simply results in slow disruption of
RVPC and progressive recovery of the sigmoidal shape of
the fusion curves when fusion is further induced at pH 6.2
and 238C. It could be tempting to relate this result to the re-
versibility of the rhabdovirus glycoprotein conformational
changes (Crimmins et al., 1983; Doms et al., 1987; Puri et al.,
1988, 1992; Clague et al., 1990; Gaudin et al., 1991, 1993; Pak
et al., 1997). However, as treatment of RVPC by proteinase
K also results in RVPC disruption without inducing any fu-
sion, this indicates that the transition from RVPC to com-
plete fusion is a high-cost energy step that depends on the in-
tegrity and the correct refolding of the glycoproteins directly
involved in the fusion process. This also rules out the hy-
pothesis that local membrane connections are sufficient to
allow spontaneous fusion of lipid bilayers in agreement with
recent results obtained by Leikina and Chernomordik
(2000) using influenza HA to induce membrane fusion. Fi-
nally, together with the fact that prolonged incubation of
RVPC with LPC at pH 6.45 and 08C also resulted in its dis-
ruption, proteolysis experiments also demonstrate that the
lipid organization in RVPC can reverse back to its initial
state (i.e., two bilayers) and that the energy cost of local
membrane merger in RVPC is compensated by the energy
provided by G conformational changes.
Toward a Universal Model for Fusion
Despite the important differences between their fusion
machineries (Gaudin, 2000), rabies virus and influenza vi-The Journal of Cell Biology, Volume 150, 2000 610
rus-induced membrane fusion follow a similar pathway
(Fig. 11). In both cases, the first step in the fusion process
is the insertion of the fusion peptide into the target mem-
brane (Stegmann et al., 1991; Tsurudome et al., 1992; Dur-
rer et al., 1995) and maybe also into the viral membrane
(Weber et al., 1994; Wharton et al., 1995). This insertion
would induce the formation of a stalk structure that con-
nects target and viral membranes. The initial stalk struc-
ture would then expand and the inner leaflets of the mem-
branes would form a hemifusion diaphragm. This step would
be followed by pore formation and expansion leading to
complete fusion. This fusion model is also supported by
data obtained from other fusion systems: stalk formation is
consistent with the lysolipid-induced inhibition of calcium-
triggered exocytosis, GTP dependent fusion of rat liver
microsomes, pH-induced fusion of insect cells infected by
baculovirus, and Sendai virus fusion with liposomes (Cher-
nomordik et al., 1993, 1995; Yeagle et al., 1994). Hemifu-
sion has been detected not only in the case of fusion in-
duced by GPI-HA (Kemble et al., 1994; Melikyan et al.,
1995b), but also in the case of fusion induced by HA hav-
ing a mutation in position 1 of HA2 (Qiao et al., 1999), and
in the case of paramyxovirus SV5 fusion protein lacking its
intraviral COOH-terminal domain (Bagai and Lamb,
1996). Finally, for both the influenza and rabies virus,
complete fusion is preceded by a stage at which lipid diffu-
sion is strongly restricted. This step seems to involve a
ring-like structure made up of activated fusogenic glyco-
proteins. Such a structure is also encountered in the case
of baculovirus GP64-induced membrane fusion (Plonsky
and Zimmerberg, 1996; Markovic et al., 1998) suggesting
that the supramolecular organization of the fusion ma-
chinery is similar from one system to another.
Although the mechanism of membrane rearrangements
leading to fusion is probably universal, depending on the
experimental conditions, fusion may be blocked at differ-
ent stages that are not the same from one system to an-
other. For example, the membrane organization is proba-
bly not the same in RVPC and FIF, as RVPC seems to be
at a more advanced stage on the fusion pathway. Thus, dis-
secting the fusion pathway of various fusion systems and
identifying stable intermediates will certainly be useful if
one wants to get a detailed cinematic view of the fusion
mechanism and to know how proteins induce this complex
process.
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